Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Bristol Myers Squibb gets USFDA nod for obstructive hypertrophic cardiomyopathy drug Camzyos

Ruchika Sharma1 May 2022 10:30 AM IST

Princeton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (USFDA) has approved Camzyos (mavacamten, 2.5 mg, 5...

Pfizer vaccines head Kathrin Jansen to retire this year

Ruchika Sharma1 May 2022 10:00 AM IST

She previously led vaccine research at vaccines and health care products maker Wyeth, which was acquired by Pfizer over a decade ago.

COVID-19: WHO backed vaccine resolution wins 24 percent support at Moderna

Ruchika Sharma1 May 2022 9:30 AM IST

The message for management from the result is "there are more important things to think about than just returns to investors," Hodgson said.

GSK Nucala application for COPD accepted for review in China

GSK, SK bioscience seek nod for SKYCovione in South Korea

Ruchika Sharma1 May 2022 9:00 AM IST

SKYCovione is a self-assembled nanoparticle vaccine candidate targeting the receptor binding domain of the SARS-CoV-2 Spike protein for the parental...

SII Covovax inclusion in vaccination drive for 12-17 age group recommended by NTAGI panel

Ruchika Sharma30 April 2022 12:26 PM IST

New Delhi: The Standing Technical Sub-Committee of the NTAGI has recommended inclusion of the Serum Institute's Covid jab Covovax in the national...

Govt to expedite process of recognition of Biological E Corbevax by other countries

Ruchika Sharma30 April 2022 11:56 AM IST

New Delhi: The government plans to expedite the process of recognition of COVID-19 vaccine Corbevax by other countries while its manufacturer...

Lupin bags tentative USFDA nod for rare autoimmune disorder drug Amifampridine

Lupin Diagnostics unveils reference lab in Guwahati

Ruchika Sharma30 April 2022 11:24 AM IST

After Assam and West Bengal, Lupin Diagnostics is also setting up laboratories in Bihar, Jharkhand and Orrisa to comprehensively cater to eastern...

Roche Diabetes Care India, Fitterfly Healthtech ink pact for diabetes management programme

Ruchika Sharma30 April 2022 9:30 AM IST

Mumbai: Roche Diabetes Care India and Fitterfly Healthtech have partnered to co-create a 90-day diabetes management programme for people with type 2...

Biocon profit declines by 4 percent to Rs 283 crore in Q4

Ruchika Sharma30 April 2022 9:00 AM IST

New Delhi: Biocon on Thursday reported a 4 per cent decline in consolidated net profit to Rs 283.9 crore in the fourth quarter ended on March 31,...

Biocon profit declines by 4 percent to Rs 283 crore in Q4

Ruchika Sharma30 April 2022 9:00 AM IST

New Delhi: Biocon on Thursday reported a 4 per cent decline in consolidated net profit to Rs 283.9 crore in the fourth quarter ended on March 31,...

Haryana ideal destination for pharma hub, says Chief Secretary

Ruchika Sharma29 April 2022 4:14 PM IST

The Chief Secretary also lauded the Trade Fair Authority Haryana for organizing expos in Chandigarh as usually the expos are organised in Gurugram and...

Wipro GE Healthcare unveils 'Made in India' Revolution Aspire CT scanner

Ruchika Sharma29 April 2022 3:12 PM IST

The rotation time in Revolution Aspire CT scanner has been increased by 20 percent, enabling clinicians to price faster diagnosis.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok